AI Engines For more Details: Perplexity Kagi Labs You
Local Anesthesia: Butacaine works by blocking nerve signals in the body, thereby temporarily numbing the area where it is applied. This effect helps to reduce pain or discomfort during procedures such as minor surgeries, dental procedures, or the insertion of catheters.
Topical Application: Butacaine is usually applied topically to the skin or mucous membranes, such as the lining of the mouth or the rectal area. It may come in the form of creams, ointments, gels, or sprays for easy application.
Rapid Onset: The combination of butamben and tetracaine in butacaine allows for a rapid onset of anesthesia, providing quick relief from pain or discomfort.
Short Duration: The duration of action of butacaine is relatively short-lived, typically lasting for a few hours. This makes it suitable for minor procedures or temporary relief of pain.
Low Systemic Absorption: When applied topically, the systemic absorption of butacaine is minimal, reducing the risk of systemic side effects. However, absorption may vary depending on factors such
| Rank | Probiotic | Impact |
|---|---|---|
| species | Akkermansia muciniphila | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Abdominal Aortic Aneurysm | 0.3 | 0.3 | |
| ADHD | 0.6 | 0.3 | 1 |
| Allergic Rhinitis (Hay Fever) | 0.4 | 0.6 | -0.5 |
| Allergies | 0.6 | 0.8 | -0.33 |
| Allergy to milk products | 0.6 | 0.6 | |
| Alzheimer's disease | 1.1 | 0.8 | 0.38 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.8 | 0.6 | 0.33 |
| Ankylosing spondylitis | 0.6 | 0.1 | 5 |
| Anorexia Nervosa | 0.3 | 0.6 | -1 |
| Antiphospholipid syndrome (APS) | 0.3 | 0.3 | 0 |
| Asthma | 0.4 | 1.1 | -1.75 |
| Atherosclerosis | 0.3 | -0.3 | |
| Atrial fibrillation | 0.6 | 0.4 | 0.5 |
| Autism | 1.9 | 1.6 | 0.19 |
| Autoimmune Disease | 0.3 | 0.3 | |
| Barrett esophagus cancer | 0.3 | -0.3 | |
| Biofilm | 0.4 | 0.4 | |
| Bipolar Disorder | 0.6 | 0.3 | 1 |
| Brain Trauma | 0.3 | 0.3 | |
| Carcinoma | 0.9 | 0.9 | |
| Celiac Disease | 0.3 | 0.6 | -1 |
| Cerebral Palsy | 0.6 | 0.6 | |
| Chronic Fatigue Syndrome | 1 | 0.4 | 1.5 |
| Chronic Kidney Disease | 0.5 | 0.8 | -0.6 |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.3 | 0.3 | 0 |
| Chronic Urticaria (Hives) | 0.3 | 0.6 | -1 |
| Coagulation / Micro clot triggering bacteria | 0.3 | 0.3 | 0 |
| Cognitive Function | 0.3 | 0.3 | 0 |
| Colorectal Cancer | 1.5 | 0.3 | 4 |
| Coronary artery disease | 0.7 | 0.1 | 6 |
| COVID-19 | 1.4 | 2.2 | -0.57 |
| Crohn's Disease | 1.2 | 1 | 0.2 |
| deep vein thrombosis | 0.3 | 0.3 | 0 |
| Denture Wearers Oral Shifts | 0.3 | 0.3 | |
| Depression | 2.1 | 2.2 | -0.05 |
| Dermatomyositis | 0.3 | 0.3 | |
| Eczema | 0.4 | 0.3 | 0.33 |
| Endometriosis | 0.3 | 0.3 | |
| Eosinophilic Esophagitis | 0.3 | -0.3 | |
| Epilepsy | 0.6 | 0.8 | -0.33 |
| Fibromyalgia | 0.5 | 0.5 | |
| Functional constipation / chronic idiopathic constipation | 0.3 | 0.1 | 2 |
| gallstone disease (gsd) | 0.1 | 0.3 | -2 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.3 | -0.3 | |
| Generalized anxiety disorder | 1 | 0.6 | 0.67 |
| Glioblastoma | 0.3 | -0.3 | |
| Gout | 0.6 | 0.3 | 1 |
| Graves' disease | 0.3 | -0.3 | |
| Gulf War Syndrome | 0.3 | 0.8 | -1.67 |
| Halitosis | 0.3 | 0.3 | 0 |
| Hashimoto's thyroiditis | 0.4 | 0.7 | -0.75 |
| Heart Failure | 0.4 | 0.4 | 0 |
| Hidradenitis Suppurativa | 0.6 | 0.6 | |
| hypercholesterolemia (High Cholesterol) | 0.6 | -0.6 | |
| hyperglycemia | 0.6 | 0.8 | -0.33 |
| Hyperlipidemia (High Blood Fats) | 0.6 | 0.6 | |
| hypersomnia | 0.3 | -0.3 | |
| hypertension (High Blood Pressure | 1.2 | 0.9 | 0.33 |
| Hypothyroidism | 0.3 | 0.3 | 0 |
| Hypoxia | 0.3 | 0.3 | |
| IgA nephropathy (IgAN) | 0.6 | 0.1 | 5 |
| Inflammatory Bowel Disease | 1.3 | 1.6 | -0.23 |
| Insomnia | 0.3 | 1.4 | -3.67 |
| Irritable Bowel Syndrome | 1.3 | 1.1 | 0.18 |
| ischemic stroke | 0.3 | 0.3 | 0 |
| Liver Cirrhosis | 1.5 | 2 | -0.33 |
| Long COVID | 1.7 | 0.9 | 0.89 |
| Lung Cancer | 0.3 | 0.6 | -1 |
| Mast Cell Issues / mastitis | 0.3 | 0.3 | |
| ME/CFS with IBS | 0.6 | 0.6 | |
| ME/CFS without IBS | 0.7 | 0.7 | |
| membranous nephropathy | 0.3 | 0.3 | |
| Menopause | 0.3 | 0.3 | 0 |
| Metabolic Syndrome | 1.3 | 1.4 | -0.08 |
| Mood Disorders | 2.6 | 1.8 | 0.44 |
| multiple chemical sensitivity [MCS] | 0.6 | 0.6 | |
| Multiple Sclerosis | 1.8 | 0.4 | 3.5 |
| Multiple system atrophy (MSA) | 0.8 | 0.8 | |
| myasthenia gravis | 0.3 | 0.3 | |
| neuropathic pain | 0.3 | 0.3 | 0 |
| Neuropathy (all types) | 0.9 | 0.9 | |
| neuropsychiatric disorders (PANDAS, PANS) | 0.3 | 0.3 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.5 | 1 | -1 |
| NonCeliac Gluten Sensitivity | 0.8 | 0.8 | |
| Obesity | 2.2 | 2.2 | 0 |
| obsessive-compulsive disorder | 0.3 | 1.3 | -3.33 |
| Osteoarthritis | 0.6 | 0.6 | 0 |
| Osteoporosis | 0.3 | 0.8 | -1.67 |
| pancreatic cancer | 0.3 | 0.3 | 0 |
| Parkinson's Disease | 2.4 | 1.3 | 0.85 |
| Polycystic ovary syndrome | 0.4 | 0.9 | -1.25 |
| primary biliary cholangitis | 0.3 | 0.3 | 0 |
| Primary sclerosing cholangitis | 0.3 | 0.1 | 2 |
| Psoriasis | 0.6 | 0.7 | -0.17 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 1.2 | 0.1 | 11 |
| Rosacea | 0.1 | 0.1 | |
| Schizophrenia | 1.4 | 0.3 | 3.67 |
| scoliosis | 0.3 | -0.3 | |
| Sjögren syndrome | 0.3 | 0.3 | 0 |
| Sleep Apnea | 0.3 | -0.3 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.3 | 0.3 | |
| Stress / posttraumatic stress disorder | 0.3 | 0.6 | -1 |
| Systemic Lupus Erythematosus | 1 | 0.4 | 1.5 |
| Tic Disorder | 0.3 | 0.3 | |
| Tourette syndrome | 0.6 | 0.6 | |
| Type 1 Diabetes | 1.1 | 0.3 | 2.67 |
| Type 2 Diabetes | 1.8 | 1.1 | 0.64 |
| Ulcerative colitis | 0.5 | 1.1 | -1.2 |
| Unhealthy Ageing | 1.3 | 0.4 | 2.25 |
| Vitiligo | 0.3 | 0.3 | 0 |
